Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Immunotherapies
 More »

  • Immunotherapies
    Berlin GERMANY http://www.informa-ls.com/event/Immunotherapies13
    12-4-2013
  • Bayer Collaboration Could Net $540M+ for Compugen
    Bayer HealthCare will team up with Compugen on preclinical research toward antibody-based cancer immunotherapies against two potential immune checkpoint targets discovered by ...
    8-5-2013
  • Stellar Taps University of Guelph C. diff Immunotherapy Technology
    for the development of human immunotherapies against Clostridium difficile ... for the development of human immunotherapies against Clostridium difficile ...
    7-31-2013
  • Celgene Halts a Phase III B-Cell CLL Trial Because of Deaths
    in elderly patients 65 and older with B-cell chronic lymphocytic leukemia (CLL), plus comorbidities that precluded treatment with more aggressive standard chemo-immunotherapies. ...
    7-18-2013
  • "Shape-Shifting" Protein Could Help Explain Variable Parkinson...
    protein. "What we've found opens up new areas for developing therapies, and particularly immunotherapies, for Parkinson's and other neurodegenerative diseases," Dr. ...
    7-3-2013
  • More Than a Messenger: A New Class of Drugs-mRNA-Based Therapeutics
    ... It is noteworthy that mRNA-based vaccines don't require any vehicle and are injected intradermally. Data presented earlier have shown that the specific mRNA-based immunotherapies ...
    6-14-2013
  • Flexibility in Biopharmaceutical Manufacturing Capacity
    Single-use bioreactors are changing the biomolecular production landscape. Biologic drugs including monoclonal antibodies, therapeutic proteins, immunotherapies, and vaccines have ...
    5-28-2013
  • The Tumor Microenvironment as a Drug Target: Chasing Slippery...
    ... inhibit FAP activity at the molecular level; she and others are also "trying to kill off the cells that express FAP with antibody-conjugated toxin and cell-based immunotherapies." ...
    5-1-2013
  • FusionVax Snags Exclusive Rights to HPV Drug in Asia
    FusionVax is a private Taiwan-based biopharmaceutical company developing immunotherapies for the treatment of HPV-associated cancers. It is committed to in-licensing and developing ...
    4-22-2013
  • Novel Platform for Immunotherapies Created
    for the creation of a new industrial platform for the production of immunotherapeutics, including Transgene's therapeutic products. Novel Platform for Immunotherapies Created
    3-26-2013
  • Medicine: Getting Personal
    ... COO and vp of manufacturing at Argos Therapeutics, presented a case study summarizing the do's and don'ts of an automated approach for scale-up of personalized immunotherapies. ...
    3-15-2013
  • Zapping Pathological Proteins in Alzheimer's
    is the basis for active and passive immunotherapies against conformation-specific targets. ... AC Immune's immunotherapies trigger the body to make antibodies against these misfolded ...
    3-1-2013
  • Rise of Cell-Based Immunotherapy
    ... While the pendulum swinging in favor of immunotherapies is not restricted to cell-based ... pipeline with a view to revisit cell-based immunotherapies with a more favorable eye. ...
    3-1-2013
  • Troubled Dendreon Sells Off NJ Plant
    to University of Pennsylvania toward creation of a Center for Advanced Cellular Therapies, under a new R&D alliance designed to advance novel T-cell immunotherapies against cancer. ...
    12-20-2012
  • Sanofi Deal Could Net Selecta Up to $900M
    The accord also gives Sanofi an option to develop two additional candidate immunotherapies for allergies, each to a specific food or aeroallergen using SVP. The platform technology ...
    11-28-2012
  • More »

    Journal Articles

  • AUTOIMMUNE THYROID DISEASE ELICITED BY NY-ESO-1 VACCINATION
    Roberto Vita, Fabrizio Guarneri, Ravin Agah, Salvatore Benvenga
    Thyroid
    AUTOIMMUNE THYROID DISEASE ELICITED BY NY-ESO-1 VACCINATION Thyroid Background. Immunotherapies and targeted therapies are frequently associated with thyroid dysfunction, which is ...
  • Redirecting Migration of T Cells to Chemokine Secreted from Tumors...
    Michael H. Kershaw, Gang Wang, Jennifer A. Westwood, Russell K. Pachynski, H. Lee Tiffany, Francesco M. Marincola, Ena Wang, Howard A. Young, Philip M. Murphy, Patrick Hwu
    Human Gene Therapy and Part B: Methods
    Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2 Human Gene Therapy and Part B: Methods T-cell-based immunotherapies provide a ...
  • DNA/Amphiphilic Block Copolymer Nanospheres Reduce Asthmatic...
    Marie Langelot, Mathieu Mével, Benoit Chatin, David Lair, Antoine Magnan, Bruno Pitard, Fanny Beilvert, Adrien Tissot, Mathieu Mevel
    Human Gene Therapy and Part B: Methods
    reactivity against allergens. The most promising treatments for asthma are based on specific immunotherapies, but they lack efficiency and can induce deleterious side effects. ...
  • Characterization of a Novel Human Anti-HIV-1 gp41 IgM Monoclonal...
    Chuanhai Cao, Yun Bai, Mary Jolene Holloway, Rebecca L. Edgeworth, Eugene A. Jackson, Joseph Cotropia, Kenneth E. Ugen
    DNA and Cell Biology
    less hypervariability than the gp120 surface envelope HIV glycoprotein, which makes it particularly a better candidate for the development of passive and active immunotherapies. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll